Gibson Dunn Advises Avere Therapeutics on Private Placement

Firm News  |  August 12, 2026

---

Gibson Dunn is advising Avere Therapeutics on its $500 million private placement.

The Gibson Dunn corporate team is led by partners Ryan Murr and Branden Berns and includes of counsel Evan Shepherd and associates Alisa Balderas and Anika Gidwani.